Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Jul 16, 2024

Total Value ($000): $335,258 (100.0% shares, 0.0% debt)

Holdings (4)

CNTA CENTESSA PHARMACEUTICALS PLC 53.8%

Value ($000) $180,267 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 22.9%

Value ($000) $76,885 Shares 7,464,572 Est. Cost $13.72 Unrealized -24.9%

NAMS NEWAMSTERDAM PHARMA COMPANY 16.4%

Value ($000) $55,124 Shares 2,869,565 Est. Cost $10.96 Unrealized +83.1%

AURA AURA BIOSCIENCES INC 6.9%

Value ($000) $22,982 Shares 3,039,892 Est. Cost $17.87 Unrealized -59.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$180,267	53.8%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$76,885	22.9%	$13.72	-24.9%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$55,124	16.4%	$10.96	+83.1%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$22,982	6.9%	$17.87	-59.0%	COM	05153U107